Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC

Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC
Co-Chairs, Nasser Altorki, MD, and Jonathan D. Spicer, MD, PhD, FRCSC, discuss NSCLC in this CME/MOC activity titled “Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC: How to Modernize Best Practices Based on New Evidence and Better Multidisciplinary Alliances.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/YRK865. CME/MOC credit will be available until February 20, 2024.